Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 2
2011 2
2013 1
2014 2
2015 3
2016 1
2017 1
2018 2
2019 1
2020 1
2021 3
2022 3
2023 2
2024 2
2025 4
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: ucalopride
Page 1
Showing results for ucalopride chronic constipation sibo
Your search for prucalopride chronic constipation SIBO retrieved no results
Epidemiology of small intestinal bacterial overgrowth.
Efremova I, Maslennikov R, Poluektova E, Vasilieva E, Zharikov Y, Suslov A, Letyagina Y, Kozlov E, Levshina A, Ivashkin V. Efremova I, et al. World J Gastroenterol. 2023 Jun 14;29(22):3400-3421. doi: 10.3748/wjg.v29.i22.3400. World J Gastroenterol. 2023. PMID: 37389240 Free PMC article. Review.
Small intestinal bacterial overgrowth (SIBO) is defined as an increase in the bacterial content of the small intestine above normal values. ...Proton pump inhibitor therapy is a significant risk factor for SIBO. The risk of SIBO increases with age and does no …
Small intestinal bacterial overgrowth (SIBO) is defined as an increase in the bacterial content of the small intestine above normal v …
Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO.
Banaszak M, Górna I, Woźniak D, Przysławski J, Drzymała-Czyż S. Banaszak M, et al. Microorganisms. 2023 Feb 24;11(3):573. doi: 10.3390/microorganisms11030573. Microorganisms. 2023. PMID: 36985147 Free PMC article. Review.
Increased lipopolysaccharide (LPS) permeability, stimulating the inflammatory response and resulting in chronic inflammation, has been identified as the leading cause of microbial overgrowth in the gut. ...This review was designed to provide an overview of the available li …
Increased lipopolysaccharide (LPS) permeability, stimulating the inflammatory response and resulting in chronic inflammation, has bee …
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome - An Update.
Takakura W, Pimentel M. Takakura W, et al. Front Psychiatry. 2020 Jul 10;11:664. doi: 10.3389/fpsyt.2020.00664. eCollection 2020. Front Psychiatry. 2020. PMID: 32754068 Free PMC article. Review.
Small intestinal bacterial overgrowth (SIBO) is one manifestation of gut microbiome dysbiosis and is highly prevalent in IBS (Irritable Bowel Syndrome). ...As a consequence, SIBO and IBS share a myriad of symptoms including abdominal pain, distention, diarrhea, and …
Small intestinal bacterial overgrowth (SIBO) is one manifestation of gut microbiome dysbiosis and is highly prevalent in IBS (Irritab …
[An Intestinal Metabolite Exacerbates Stress-induced Diarrhea].
Ishihara N, Kimura S, Hase K. Ishihara N, et al. Yakugaku Zasshi. 2025;145(8):667-672. doi: 10.1248/yakushi.24-00190-2. Yakugaku Zasshi. 2025. PMID: 40754409 Free article. Review. Japanese.
Irritable bowel syndrome (IBS) constitutes a chronic functional gastrointestinal disorder characterized by abdominal pain and irregular bowel habits. ...IBS manifests with diverse symptoms attributable to aberrant intestinal function, including diarrhea, constipation …
Irritable bowel syndrome (IBS) constitutes a chronic functional gastrointestinal disorder characterized by abdominal pain and irregul …
Advances in capsule-based fecal microbiota transplantation: clinical applications and innovations.
Yu H, Zhang Y, Yang D, Luo H, Zhou Y. Yu H, et al. J Transl Med. 2025 Dec 2;23(1):1370. doi: 10.1186/s12967-025-07407-0. J Transl Med. 2025. PMID: 41331614 Free PMC article. Review.
It also alleviates symptoms and enhances microbiota diversity in small intestinal bacterial overgrowth (SIBO). However, the clinical benefits remain inconsistent for individuals with in irritable bowel syndrome (IBS) and functional constipation (FC), despite alterat …
It also alleviates symptoms and enhances microbiota diversity in small intestinal bacterial overgrowth (SIBO). However, the clinical …
The impact of small intestinal bacterial overgrowth on the efficacy of fecal microbiota transplantation in patients with chronic constipation.
Wang L, Xu Y, Li L, Yang B, Zhao D, Ye C, Lin Z, Cui J, Liu Y, Zhu W, Li N, Tian H, Chen Q. Wang L, et al. mBio. 2024 Oct 16;15(10):e0202324. doi: 10.1128/mbio.02023-24. Epub 2024 Aug 28. mBio. 2024. PMID: 39194187 Free PMC article.
Based on the results of the SIBO breath test, the patients were divided into two groups: the constipation with SIBO group (SIBO) and the constipation without SIBO group (non-SIBO). ...Chronic constipation patients wit …
Based on the results of the SIBO breath test, the patients were divided into two groups: the constipation with SIBO gro …
Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
Sarosiek I, Bashashati M, Alvarez A, Hall M, Shankar N, Gomez Y, McCallum RW, Sarosiek J. Sarosiek I, et al. Am J Med Sci. 2016 Sep;352(3):231-8. doi: 10.1016/j.amjms.2016.05.012. Epub 2016 May 24. Am J Med Sci. 2016. PMID: 27650225
BACKGROUND: Lubiprostone is an effective treatment for chronic constipation (CC). The mechanism of action of lubiprostone is through increasing fluid secretion and lubrication of the intestinal lumen. The effects of lubiprostone on gastrointestinal transit and small …
BACKGROUND: Lubiprostone is an effective treatment for chronic constipation (CC). The mechanism of action of lubiprostone is t …
Hydrogen breath tests in gastrointestinal diseases.
Rana SV, Malik A. Rana SV, et al. Indian J Clin Biochem. 2014 Oct;29(4):398-405. doi: 10.1007/s12291-014-0426-4. Epub 2014 Mar 21. Indian J Clin Biochem. 2014. PMID: 25298621 Free PMC article. Review.
Glucose hydrogen breath test is more acceptable for diagnosis of SIBO whereas lactose and fructose hydrogen breath tests are used for detection of lactose and fructose maldigestion respectively. ...Patients with symptoms of abdominal pain, bloating, flatulence and altered …
Glucose hydrogen breath test is more acceptable for diagnosis of SIBO whereas lactose and fructose hydrogen breath tests are used for …
Capsules for the Diagnosis and Treatment of Gastrointestinal Motility Disorders- A Game Changer.
Sonu I, Oh SJ, Rao SSC. Sonu I, et al. Curr Gastroenterol Rep. 2024 Jun;26(6):157-165. doi: 10.1007/s11894-024-00926-8. Epub 2024 Apr 17. Curr Gastroenterol Rep. 2024. PMID: 38630422 Review.
In the therapeutics arena, an orally ingested vibrating capsule has been recently FDA approved for the treatment of chronic constipation, supported by a robust phase 3 clinical trial which showed significant improvement in constipation symptoms and quality of …
In the therapeutics arena, an orally ingested vibrating capsule has been recently FDA approved for the treatment of chronic consti …
Intestinal Involvement in Systemic Sclerosis: A Clinical Review.
Sakkas LI, Simopoulou T, Daoussis D, Liossis SN, Potamianos S. Sakkas LI, et al. Dig Dis Sci. 2018 Apr;63(4):834-844. doi: 10.1007/s10620-018-4977-8. Epub 2018 Feb 21. Dig Dis Sci. 2018. PMID: 29464583 Review.
The pathogenesis of intestinal involvement includes vascular damage, nerve dysfunction, smooth muscle atrophy, and fibrosis, causing hypomotility, which leads to small intestinal bacterial overgrowth (SIBO), malabsorption, malnutrition, diarrhea, pseudo-obstruction, con …
The pathogenesis of intestinal involvement includes vascular damage, nerve dysfunction, smooth muscle atrophy, and fibrosis, causing hypomot …
30 results